The Anabolic and Catabolic Effect of Loaded and Unloaded Exercise on Articular Cartilage Health

June 28, 2023 updated by: University of Manitoba

A Preliminary Study on the Effect of Loaded and Unloaded Exercise on Anabolic and Turnover Activity of Articular Cartilage in Healthy Young Adults

The serum concentration of cartilage oligomeric matrix protein (sCOMP) has been considered a mechano-sensitive biomarker of articular cartilage turnover, and N-propeptide of type II collagen (PIIANP) is a proposed biomarker of type II collagen synthesis. Few studies have investigated both the anabolic and turnover response of articular cartilage as a result of acute changes in body weight mass during exercise. Using a repeated measures cross-over design, fifteen healthy adults (age 18-30 years) performed three, 30-minute bouts of treadmill walking exercise under 3 loading conditions: (1) control (no alteration to body mass); (2) loaded (12% increase in body mass using a weighted vest); and (3) unloaded (12% decrease in body mass using lower body positive pressure). Venous blood was collected before, immediately after, and 15 and 30 minutes after exercise to investigate cartilage turnover (sCOMP) and anabolism (PIIANP).

Study Overview

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Manitoba
      • Winnipeg, Manitoba, Canada, R3T 2N2
        • University of Manitoba

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy
  • 18-30 years old

Exclusion Criteria:

  • Traumatic injury to the lower extremity in the past year
  • Hip, knee, or ankle surgery
  • Radiographic evidence of joint degeneration
  • Cardiovascular disease
  • Ankylosing spondylitis
  • Psoriatic arthritis
  • Chronic reactive arthritis
  • Renal problems requiring peritoneal dialysis or hemodialysis
  • Not currently using any prescription or non-prescription medications and/or nutritional supplements

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Control
The control condition did 30 minutes of walking exercise with their own body mass.
Control (no alteration to body mass).
Experimental: +12% Body Mass
The +12% body mass condition did 30 minutes of walking exercise wearing a weighted vest with +12% of their body mass applied.
Loaded walking exercise (12% increase in body mass using a weighted vest).
Experimental: -12% Body Mass
The -12% body mass condition did 30 minutes of walking exercise using a lower body positive pressure treadmill with -12% of their body mass applied.
Unloaded walking exercise (12% decrease in body mass using lower body positive pressure).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Serum cartilage oligomeric matrix protein (sCOMP)
Time Frame: sCOMP was measured at baseline, immediately post, and 15- and 30-minutes post exercise.
The systemic blood serum concentration of sCOMP was evaluated in all participants under the 3 conditions in a crossover trial.
sCOMP was measured at baseline, immediately post, and 15- and 30-minutes post exercise.
N-propeptide of type II collagen (PIIANP)
Time Frame: PIIANP was measured at baseline, immediately post, and 15- and 30-minutes post exercise.
The systemic blood serum concentration of PIIANP was evaluated in all participants under the 3 conditions in a crossover trial.
PIIANP was measured at baseline, immediately post, and 15- and 30-minutes post exercise.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephen M Cornish, PhD, University of Manitoba

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 27, 2019

Primary Completion (Actual)

March 1, 2020

Study Completion (Actual)

March 1, 2020

Study Registration Dates

First Submitted

June 21, 2023

First Submitted That Met QC Criteria

June 21, 2023

First Posted (Actual)

June 29, 2023

Study Record Updates

Last Update Posted (Actual)

July 3, 2023

Last Update Submitted That Met QC Criteria

June 28, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • HS22322

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The data will not be available to other researchers as we do not have ethical approval to do so.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Control Condition

Subscribe